Core Viewpoint - The controlling shareholder of Jinhe Biological, Inner Mongolia Jinhe Holdings Co., Ltd., has completed its share reduction plan, selling a total of 22,563,100 shares, which accounts for 3% of the company's total share capital after excluding repurchased shares [1][2]. Group 1: Share Reduction Details - The share reduction plan was initially announced on May 17, 2025, with the reduction period set from June 10, 2025, to September 9, 2025 [1]. - The reduction was executed through two methods: a block trade and centralized bidding, with a maximum of 7,521,130 shares (1% of total share capital) sold via centralized bidding and 15,042,259 shares (2% of total share capital) sold via block trade [1]. - The average selling price for the block trade was 6.81 yuan, while the average price for the centralized bidding was 7.26 yuan, resulting in a total cash-out amount of approximately 157,039,161 yuan [2]. Group 2: Shareholding Changes - Prior to the reduction, the controlling shareholder and its concerted actors held a total of 278,744,052 shares, representing 37.0615% of the total share capital after excluding repurchased shares [2]. - After the reduction, the total shares held by the controlling shareholder and its concerted actors decreased to 256,180,952 shares, which is 34.0615% of the total share capital after excluding repurchased shares [2]. - Specifically, Inner Mongolia Jinhe Holdings now holds 219,195,570 shares, accounting for 29.1440% of the total share capital after excluding repurchased shares [2]. Group 3: Source of Reduced Shares - The shares being reduced originated from the previous controlling shareholder, Inner Mongolia Jinhe Construction and Installation Co., Ltd., due to a division of the company, which included shares acquired before the initial public offering and through non-public offerings, as well as shares from capital increases and stock distributions [3]. Group 4: Completion of the Plan - As of the announcement date, the share reduction plan has been fully implemented [4].
金河生物控股股东22天减持2256万股 套现1.57亿元